Wuhan Weiao Pharmaceutical

Wuhan Weiao Pharmaceutical is a Chinese pharmaceutical and health product company established in 1996 and based in Wuhan. As a subsidiary of Vital Health Holdings Group, the company focuses on the research, development, manufacturing, and commercialization of prescription drugs, over-the-counter medicines, and nutritional supplements. Its flagship brand, Leli, utilizes advanced amino acid chelation technology to produce highly absorbable mineral supplements for bone and intestinal health. Additionally, the company manufactures biological therapeutics, including a recombinant human interferon alpha-2a suppository for viral infections. Wuhan Weiao Pharmaceutical operates GMP-certified production lines for oral solid dosages and suppositories to serve the domestic healthcare market.